McCarthy Consultant Services Inc. - Regulatory Affairs Consulting for the Healthcare Industry

Boehringer Ingelheim - Contract Development and Large-Scale Manufacturing of Biopharmaceuticals

Biovian - Contract Manufacturing Of Biopharmaceuticals

Quanticate - Collecting, Analyzing and Reporting Clinical and Safety Data for Clinical and Post-Market Studies

Tissue Solutions - High-Quality Human Tissues and Biological Materials

Meet Biovian at the Biotech Outsourcing Strategies Conference
Meet Biovian at the Biotech Outsourcing Strategies cmc2012 (BOS cmc) on 14 June 2012 at the Sohuset Conference Center, Denmark. Biovian's director of business development and projects, Dr Knut Ringbom, will be available for in-depth discussions with delegates at the conference.

Meet Biovian at Lyckad Läkemedelsutveckling in Stockholm
Meet Biovian at 'Lyckad Läkemedelsutveckling' seminar on 31 May 2012 at Hotel Grand, Stockholm, Sweden. Biovian's Director of Business Development and Projects, Dr Knut Ringbom will be available for in-depth discussions with delegates at Biovian's stand.

Fujifilm Diosynth Biotechnologies Invests in New Equipment and Labs at UK Facility
Fujifilm Diosynth Biotechnologies has completed the first phase of a £3m ($4.5m) investment in new equipment and laboratories at its Billingham, UK site.

Tissue Solutions Achieves Certification to ISO 9001
Tissue Solutions is pleased to announce that it has been awarded ISO 9001:2008 BSI accreditation.

GlycoMar Releases New White Paper: Oligosaccharides in Drug Discovery
Glycobiology is concerned with the study of structure, biosynthesis, and function of saccharides (sugar chains), which may exist purely or conjugated to other biological molecules to form glycoconjugates.

Cocrystals in the Pharmaceutical and Fine Chemicals Industry: From an Option to an Opportunity
In the drug discovery and development arena it is well known that the choice of the right solid form can have a dramatic influence on the successful development of an active...

Oligosaccharides in Drug Discovery
Glycobiology offers enormous untapped potential in the discovery of new therapeutics derived from saccharides or other molecules which target the biosynthesis and function of...

Making the Most of Your Scale Down Model
While process understanding can come from a variety of sources, scaled down process models of unit operations have particular...

Xbrane Fact Sheets: Lemo System® and Rhamex System™
Xbrane Bioscience aims to simplify protein production. We offer technology and know-how to fulfil your protein expression goals, including Lemo21(DE3) competent cells and the pLemo...

Premium HPLC-Purified Peptides
Peptide Specialty Laboratories (PSL) specializes in the production of premium peptides for customers throughout Europe and...

Pinpoint accuracy: programmable nanoparticles and future cancer treatments
Most cancer drugs are not as effective as doctors would like them to be because the amount that can be administered is limited by toxicity. But a new technology, Accurin, which utilises programmable nanoparticles, is set to change all that. Elly Earls sits down with BIND Biosciences CEO Scott Minick to find out how this targeted nanotherapeutic could mark the beginning of a new era in cancer therapy.

Pharma Technology Focus - Issue 13
From advances in robotic research to new cures for addictions and life-threatening diseases, drug developers are opening up new frontiers.

Small players, big drugs – pharmaceutical SMEs take the innovative edge
Medical advances are leading to more novel therapeutics but it's small biotech, not Big Pharma, which stands to gain the most. Elly Earls meets the brains behind some of the most innovative medicines currently breaking into the market to find out whether it's time for the pharmaceutical giants to move aside.

Pharma Technology Focus - Issue 12
In this issue we focus on trends and innovations in pharmaceutical packaging.

Pharma Technology Focus - Issue 11
In this issue we look at technological advances in the area of manufacturing and APIs and explore some of the challenges faced by companies working in this sector.

Boostrix – Vaccine for Whooping Cough, Tetanus and Diphtheria
Boostrix is a three-in-one vaccine administered to protect against whooping cough, tetanus and diphtheria. Vaccination is an effective way to protect against them.

Sutent (Sunitinib Malate) - Treatment for Pancreatic Neuroendocrine Tumours
Sutent (sunitinib malate) is an oral multikinase inhibitor which is indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumours (NET).

Dulera (Mometasone Furoate and Formoterol Fumarate Dihydrate) - Treatment for Asthma
Dulera (mometasone furoate and formoterol fumarate dihydrate) is a new fixed-dose combination inhaler for the treatment of asthma.

Erwinaze (Asparaginase Erwinia Chrysanthemi) - Treatment for ALL
Erwinaze (asparaginase Erwinia chrysanthemi) is indicated for the treatment of acute lymphoblastic leukaemia (ALL). It is manufactured by EUSA Pharma.

Surfaxin (Lucinactant) - Treatment for Preventing Infant RDS
Surfaxin (Lucinactant) is a non-pyrogenic pulmonary surfactant used for the prevention of respiratory distress syndrome (RDS) in premature infants.